Graft vascular

Althongh many synthetic polymers have been used, none, including PET and ePTEE, are ideal. Much of current research focuses on coatings for improving compatibility, especially for small diameter grafts. 

State [65, 66], and can be molded into tubular form with diameter of 6 mm [44, 54], 

Fibrin on the other hand has remarkable elasticity and can extend up to 330% of its original length [67], Also, cross-linked fibrin is part of the circulatory system that was tested to be relatively non-thrombogenic [68, 69], Yet, BC falls short in elongation when compared to native BV [69] and fibrin reveals insufficient strength when subjected to physiological environments [47, 70], 

Similar to bacterial cellulose, NCC is biocompatible, stable, chemically inactive, and physiologically inert [58]. Moreover, NEC s nanoscale size allows for easy dispersion and its superior strength can provide effective reinforcement to a low strength matrix such as fibrin. These characteristics make NCC a promising nanobiomaterial for SDRVG application. 

In Brown s subsequent work [50], the potential of synthesizing new nanocomposites from NCC and fibrin for small-diameter replacement vascular graft [SDRVG] application was demonstrated Fig. 3.4. 

---

Vascular grafts are tubular devices implanted throughout the body to replace blood vessels which have become obstmcted by plaque, atherosclerosis, or otherwise weakened by an aneurysm. Grafts are used most often in peripheral bypass surgery to restore arterial blood flow in the legs. 

Polyurethanes as Biomaterials. Much of the progress in cardiovascular devices can be attributed to advances in preparing biostable polyurethanes. Biostable polycarbonate-based polyurethane materials such as Corethane (9) and ChronoFlex (10) offer far-reaching capabiUties to cardiovascular products. These and other polyurethane materials offer significant advantages for important long-term products, such as implantable ports, hemodialysis, and peripheral catheters pacemaker interfaces and leads and vascular grafts. 

The worldwide market for vascular grafts was approximately 150 million and growing at about 5% annuaUy as of 1995. The vascular graft area has tremendous market potential in development of smaU-diameter grafts of 3—4 mm for coronary bypass surgery. The total market for the intra-aortic baUoon pump, a cardiac-assist device, is ca 80 million worldwide. About 75,000 patients were supported by these baUoon pumps in 1994. This market is thought to have peaked. 

Intraaortic balloon Angioplasty catheter Vascular grafts Sutures... 

Chuang TH et al (2009) Polyphenol-stabilized tubular elastin scaffolds for tissue engineered vascular grafts. Tissue Eng Part A 15(10) 2837-2851... 

The suitable materials for the above mentioned domains are polymers, metals and ceramics. Among these, polymers play an important role. Even the polymers have a lot of remarkable properties that could be used in biomaterials design, the interaction between these artificial materials and tissues and blood could create serious medical problems such as clot formation, activating of platelets, and occlusion of tubes for dialysis or vascular grafts. In the last few years, novel techniques of synthesis have been used to correlate desirable chemical, physical and biological properties of biomaterials. 

Over half a million vascular graft replacements are performed yearly. Most of these grafts are made of PET and PTFE. These relatively large diameter grafts work when blood flow is rapid, but they generally fail for smaller vessels. 

AMI, acute massive PE, DVT, some occluded vascular grafts Action Activates plasminogen to plasmin that degrades fibrin Dose Adults. PE Load... 

As an integral member of THI s animal research team, Brano designed and preformed studies involving myocardial protection during cardiac operations, as well as temporary and permanent mechanical circulatory assist devices, heart valve prostheses, and synthetic vascular grafts. In addition he authored, and co- authored approximately 300 publications, and oversaw the writing of numerous heart failure and transplant protocols. 

Porous materials may have a closed porosity, which lowers their density and can be varied to optimise their mechanical properties, as this is carried out for some kinds of vascular grafts. For such materials, surface morphology must fulfil same requirements as those fulfilled by compact materials. 

E. Chignier, J. Guidollet, Y. Heynen, M. Serres, G. Clendinnen, P. Louisot, R. Eloy, Macromolecular, histological, ultrastructural and immunocytochemical characteristics of the neointima developed within PTFE vascular grafts. Experimental study in dogs, J. Biomed. Mater. Res. 17(4) (1983) 623-636. 

More compliant highly fluorinated polymers for reconstructive surgery (e.g., vascular grafts) and other surgical devices will undoubtedly be developed. Various ophthalmologic aids are also being commonly used. 

Artificial biologies, whelher soff or hard, can be categorized as eifher temporary (short term) or permanent (long term) in their intended application. Most, but certainly not all, polymers for biomedical applications are of the short-term type and include sutures, drug delivery devices, temporary vascular grafts and stents, tissue scaffolds. 

Biocompatibility (See Table 1), which is a phenomenological concept, is the essential property of biomaterials. For instance, the inner surface of an implanted vascular graft or blood pump (artificial heart) must be blood-compatible, while its outer surface must be tissue-compatible. In other words, the material surfaces must not exert any adverse elfects upon blood or tissue, or upon other biological elements at the interfaces. 

A variety of researches on bio-conjugate (or bio-mimicking) materials have been carried out during the last few years. As seen in Table 1, the aims and scope of many of the researchers are directly connected with clinical applications. For instance, endothelial-cell seeding (or sodding) on the luminal surface of vascular grafts is a widely-known technique [165-169] for improving the blood compatibility of polymetric materials. On the other hand, not a few of researchers are oriented to the exploitation of future possibilities of biomaterials. 

An A-B-A-type block copolymer (HEMA-St-HEMA) was shown to form a microdomain structure and to exhibit excellent blood compatibility in both in vitro and ex vivo examinations. For instance, the luminal surface of the HEMA-STY coated vascular graft was bare without detectable thrombi after 372-day implantation in dog carotid aortas. The excellent blood compatibility was discussed by taking results of the unique mode of protein adsorption of HEMA-STY surface into account. 

Nagai, N., Nakayama, Y., Zhou, Y. M., Takamizawa, K., Mori, K., and Munekata, M. (2008). Development of salmon collagen vascular graft Mechanical and biological properties and preliminary implantation study. J. Biomed. Mater. Res. 87B, 432-439. 

Schaffer LW, Davidson JT, Vlasuk GP, Dunwiddie CT, Siegel PKS. Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons. Arteriosclerosis and Thromb 1992 12 879-885. 

Other recently developed biomaterials will be used for quite different purposes in tissue engineering such as artificial pancreas and liver, artificial skin, nerve regeneration, gene therapy vascular grafts, cornea replacement and others.3... 

---